ICTA

ICTA is a privately-held international CRO with 32 years of clinical R&D, pharmaco-epidemiology, expanded access programs for APIs, cell therapies, diagnostics, and medical devices experience. ICTA has international operations throughout Western/Eastern Europe and the USA that offer full clinical research or "a la carte" services in traditional and adaptive clinical trials from Early Phase to Late Phase across a broad range of therapeutic areas. ICTA is one of the first few CROs to be able to design and effectively conduct Bayesian and adaptive clinical trials, including seamless studies, due to its active participation in an international academic network and secure information system (I-SIT platform).